4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening

Informacje na temat projektu

4-IN THE LUNG RUN

Identyfikator umowy o grant: 848294

DOI

10.3030/848294

Data podpisania przez KE 6 Grudnia 2019

Data rozpoczęcia 1 Stycznia 2020

Data zakończenia 31 Grudnia 2025

Finansowanie w ramach

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Koszt całkowity

€ 7 999 948,75

Wkład UE

€ 7 999 948,75

Koordynowany przez

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Documents, reports (15)

recruitment: description target population/ area

Description of dominant MPSG in high risk areas (that tend to elect not to participate but which are at high risk), and of MPSG for optimisation in those who tend to participate (M6)

Biomarkers: Validation circulating miRNA

Validation of two different computational models of circulating miRNAs to maximize sensitivity for risk prediction and specificity for differential diagnosis

Project Management: informed consent form

- The informed consent procedures that will be implemented for the participation of humans will be explained into detail. - providing templates of the informed consent form (per country)

Biomarkers: composite risk predicting panel

Combination of miRNAs, inflammatory proteins and cardio-pulmonary damage in a composite risk predicting panel.

recruitment: development tailored recruitment

Identification of the preferred per country and most effective channels of communication and development of the tailored intervention, with different MPSG profiles, at high risk of developing lung cancer, including qualitative data on the participants’ view of the methods

Smoking cessation: report on biofeedback CT

Report about which information about lung cancer risk and risk for developing co-morbidities (e.g. Coronary Artery Disease reflected by the coronary artery calcification (Agatston score), COPD) derived from the CT scan could be useful in motivating smokers to quit smoking

Health communication: evaluation (non-)participants

Report on informed choice (non)-participants

recruitment: evaluation tailored recruitment

Report that describes and compares the effects and efficacy of the general and tailored recruitment approaches

Protocol: study protocol 4-IN-THE-LUNG-RUN

Design of the study protocol

Data protection: security

A description of the security measures that will be implemented to prevent unauthorised access to personal data or the equipment used for processing

Smoking cessation: development smoking cessation intervention

Report on barriers and facilitators for participating in lung cancer screening, receiving personal health information and smoking cessation.

Protocol: Nodule Management Strategy

design of the lung cancer nodule management protocol

recruitment: testing tailored recruitment

Implemented testing of each type of tailored intervention in relevant areas of partner 3 iDNA, using quantitative and qualitative (interview) responses from participants to refine the intervention as we do so, in an iterative approach, until we have established that the proposed interventions are acceptable and feasible to the target groups, and establish differences in recruitment rate after 12 months of recruitment

Approval: study protocol - registration

i Final version of study protocol as submitted to regulatorsethics committees ii Registration number of clinical study in a WHOor ICMJE approved registry with the possibility to post resultsiii Approvals ethics committees and national competent authority if applicable required for invitationenrolment of first subject in at least one clinical centre

Data protection: privacy - anonymised/ pseudomysed data

explain why the research data will not be anonymised/ pseudonymised

Publikacje

Peer reviewed articles (21)

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges

Autorzy: Kevin Haaf, Carlijn M. Aalst, Harry J. Koning, Rudolf Kaaks, Martin C. Tammemägi
Opublikowane w: International Journal of Cancer, Numer 149/2, 2021, Strona(/y) 250-263, ISSN 0020-7136
Wydawca: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33578

Implementation of lung cancer screening: what are the main issues?

Autorzy: Carlijn M. van der Aalst, Kevin ten Haaf, Harry J. de Koning
Opublikowane w: Translational Lung Cancer Research, Numer 10/2, 2021, Strona(/y) 1050-1063, ISSN 2218-6751
Wydawca: AME Publishing Company
DOI: 10.21037/tlcr-20-985

Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening

Autorzy: James L. Mulshine, Bruce Pyenson, Cheryl Healton, Carolyn Aldige, Riccardo S. Avila, Torsten Blum, Matthew Cham, Harry J. de Koning, Sean B. Fain, John K. Field, Raja Flores, Maryellen L. Giger, Ilya Gipp, Frederic W. Grannis, Jan Willem C. Gratama, Ella A. Kazerooni, Karen Kelly, Harriet L. Lancaster, Luis Montuenga, Kyle J. Myers, Morteza Naghavi, Raymond Osarogiagbon, Ugo Pastorino, Anthony P.
Opublikowane w: European Journal of Cancer, Numer 218, 2025, Strona(/y) 115264, ISSN 0959-8049
Wydawca: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2025.115264

Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trial

Autorzy: Gabriella Sozzi, Federica Sabia, Luigi Rolli, Miriam Segale, Paola Suatoni, Anna Zanghi, Margherita Ruggirello, Alfonso Marchianò, Mattia Boeri, Ugo Pastorino
Opublikowane w: Journal of Experimental & Clinical Cancer Research, Numer 44, 2025, ISSN 1756-9966
Wydawca: Springer Science and Business Media LLC
DOI: 10.1186/s13046-025-03424-5

Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer

Autorzy: Harriet L. Lancaster, Anna N.H. Walstra, Kyle Myers, Ricardo S. Avila, Jan Willem C. Gratama, Marjolein A. Heuvelmans, Sean B. Fain, David A. Clunie, Ella A. Kazerooni, Maryellen L. Giger, Anthony P. Reeves, Jens Vogel-Claussen, Harry de Koning, Rowena Yip, Luis M. Seijo, John K. Field, James L. Mulshine, Mario Silva, David F. Yankelevitz, Claudia I. Henschke, Matthijs Oudkerk
Opublikowane w: European Journal of Cancer, Numer 220, 2025, Strona(/y) 115323, ISSN 0959-8049
Wydawca: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2025.115323

Annual Progression of Coronary Artery Calcium Agatston Score in The 4-IN-THE-LUNG-RUN Lung Cancer Screening Trial

Autorzy: A. Walstra, S. Zhang, K. Togka, C. Van Der Aalst, H. De Koning, M. Oudkerk
Opublikowane w: Journal of Cardiovascular Computed Tomography, Numer 19, 2025, Strona(/y) S31, ISSN 1934-5925
Wydawca: Elsevier BV
DOI: 10.1016/j.jcct.2024.12.081

Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial

Autorzy: Mattia Boeri, Federica Sabia, Roberta E. Ledda, Maurizio Balbi, Paola Suatoni, Miriam Segale, Anna Zanghì, Anna Cantarutti, Luigi Rolli, Camilla Valsecchi, Giovanni Corrao, Alfonso Marchianò, Ugo Pastorino, Gabriella Sozzi
Opublikowane w: The Lancet Regional Health - Europe, Numer 46, 2024, Strona(/y) 101070, ISSN 2666-7762
Wydawca: Elsevier BV
DOI: 10.1016/j.lanepe.2024.101070

Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling study

Autorzy: Koen de Nijs, Kevin ten Haaf, Dana Moldovanu, Juul Hubert, Isabelle van den Bosch, Anouk Eijkelboom, Carlijn van der Aalst, Harry J. de Koning
Opublikowane w: eClinicalMedicine, Numer 88, 2025, Strona(/y) 103446, ISSN 2589-5370
Wydawca: Elsevier BV
DOI: 10.1016/j.eclinm.2025.103446

P1.15-03 Dedicated Cardiovascular Screening in Lung Cancer Screening: Preliminary Results from the European 4-IN-THE-LUNG-RUN Trial,

Autorzy: M. Vonder, C. van der Aalst, J. Hubert, D. Moldovanu, A. Schmitz, J.W.C. Gratama, M. Silva, H. de Koning, M. Oudkerk
Opublikowane w: Journal of Thoracic Oncology, Numer Volume 18, Numer 11, Supplement, 2023, 2023, Strona(/y) Pages S218-S219, ISSN 1556-0864
Wydawca: Lippincott Williams & Wilkins Ltd.
DOI: 10.1016/j.jtho.2023.09.355

Lung cancer screening implementation: turning evidence into practice

Autorzy: Marjolein A Heuvelmans
Opublikowane w: The Lancet Oncology, Numer 26, 2025, Strona(/y) 535-537, ISSN 1470-2045
Wydawca: The Lancet Publishing Group
DOI: 10.1016/s1470-2045(25)00138-x

Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands

Autorzy: Koen de Nijs, Kevin ten Haaf, Carlijn van der Aalst, and Harry J. de Koning
Opublikowane w: eClinical Medicine, Numer 2024; 102570, 2024, Strona(/y) 102570, ISSN 2589-5370
Wydawca: Elsevier BV
DOI: 10.1016/j.eclinm.2024.102570

Cardiovascular Screening In Lung Cancer Screening: The European Prospective Approach 4-in-the-lung-run

Autorzy: M. Vonder, C. van der Aalst, D. Moldovanu, J. Hubert, A. Schmitz, J. Gratama, M. Silva, H. de Koning, M. Oudkerk
Opublikowane w: Journal of Cardiovascular Computed Tomography, Numer Volume 17, Numer 4, Supplement, 2023, Strona(/y) S46, ISSN 1934-5925
Wydawca: Elsevier BV
DOI: 10.1016/j.jcct.2023.05.116

Feasibility of AI as First Reader in the 4-IN-THE-LUNG-RUN Lung Cancer Screening Trial: Impact on Negative-Misclassifications and Clinical Referral Rate

Autorzy: Anna N H Walstra, Harriet L Lancaster, Marjolein A Heuvelmans, Carlijn M van der Aalst, Juul Hubert, Dana Moldovanu, Sytse F Oudkerk, Daiwei Han, Jan Willem C Gratama, Mario Silva, Harry J de Koning, Matthijs Oudkerk
Opublikowane w: European Journal of Cancer, 2024, Strona(/y) 115214, ISSN 0959-8049
Wydawca: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2024.115214

Lung cancer screening and smoking cessation efforts

Autorzy: Dana Moldovanu, Harry J. de Koning, Carlijn M. van der Aalst
Opublikowane w: Translational Lung Cancer Research, Numer 10/2, 2021, Strona(/y) 1099-1109, ISSN 2218-6751
Wydawca: AME Publishing Company
DOI: 10.21037/tlcr-20-899

Screening for multiple cancers: evaluation must go beyond aggregate measures

Autorzy: Thomas Callender, Katherine Payne, Nora Pashayan, Anne Mackie
Opublikowane w: BMJ, 2025, Strona(/y) e081098, ISSN 1756-1833
Wydawca: BMJ
DOI: 10.1136/bmj-2024-081098

P1.14-04 European Lung Cancer Screening Implementation: 4-IN-THE-LUNG-RUN trial

Autorzy: C. van der Aalst, M. Vonder, J. Hubert, D. Moldovanu, A. Schmitz, S. Delorme, R. Kaaks, K. ten Haaf , M. Oudkerk, H. de Koning
Opublikowane w: Journal of Thoracic Oncology, Numer Volume 18, Numer 11, Supplement, November 2023, 2023, Strona(/y) Page S217, ISSN 1556-1380
Wydawca: Elsevier
DOI: 10.1016/j.jtho.2023.09.352

MA19.06 Artificial Intelligence as Concurrent Reader in Prospective European Lung Cancer Screening (4-IN-THE-LUNG-RUN) Trial

Autorzy: M. Vonder, C. van der Aalst, J. Hubert, D. Moldovanu, A. Schmitz, S. Delorme, J.W. Gratama, M. Silva, H. de Koning, M. Oudkerk
Opublikowane w: Journal of Thoracic Oncology, Numer Volume 18, Numer 11, Supplement, November 2023, 2023, Strona(/y) Page S172, ISSN 1556-1380
Wydawca: Elsevier
DOI: 10.1016/j.jtho.2023.09.256

Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research

Autorzy: Harriet L. Lancaster, Marjolein A. Heuvelmans, Matthijs Oudkerk
Opublikowane w: Journal of Internal Medicine, Numer 292, 2023, Strona(/y) 68-80, ISSN 0954-6820
Wydawca: Blackwell Publishing Inc.
DOI: 10.1111/joim.13480

Lung cancer volume doubling time by computed tomography: A systematic review and meta-analysis

Autorzy: Beibei Jiang, Daiwei Han, Carlijn M. van der Aalst, Harriet L. Lancaster, Marleen Vonder, Jan-Willem C. Gratama, Mario Silva, John K. Field, Harry J. de Koning, Marjolein A. Heuvelmans, Matthijs Oudkerk
Opublikowane w: European Journal of Cancer, Numer 212, 2025, Strona(/y) 114339, ISSN 0959-8049
Wydawca: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2024.114339

Impact of recruitment method on informed decision-making in lung cancer screening in the 4-IN-THE-LUNG-RUN trial

Autorzy: Juul Hubert, Dana Moldovanu, Isabelle van den Bosch, Koen de Nijs, Kevin ten Haaf, Matthijs Oudkerk, Harry J. de Koning, Carlijn M. van der Aalst
Opublikowane w: Lung Cancer, Numer 207, 2025, Strona(/y) 108686, ISSN 0169-5002
Wydawca: Elsevier BV
DOI: 10.1016/j.lungcan.2025.108686

Histological proven AI performance in the UKLS CT lung cancer screening study: Potential for workload reduction

Autorzy: Harriet L. Lancaster, Beibei Jiang, Michael P.A. Davies, Jan Willem C. Gratama, Mario Silva, Jaeyoun Yi, Marjolein A. Heuvelmans, Geertruida H. de Bock, Anand Devaraj, John K. Field, Matthijs Oudkerk
Opublikowane w: European Journal of Cancer, Numer 220, 2025, Strona(/y) 115324, ISSN 0959-8049
Wydawca: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2025.115324